NCT05178030
The GALLOP-11 Study No drug interventions Not Available Not Available recruiting NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics No drug interventions treatment Not Available active_not_recruiting NCT05381753
Safety and Efficacy of Avapritinib in Chinese Patients with Gastrointestinal Stromal Tumor (GIST) in the Real World Not Available Not Available active_not_recruiting NCT00385203
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). treatment 2 completed NCT00585221
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients treatment 2 terminated NCT00276302
Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) treatment 1 completed NCT03556384
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) treatment 2 active_not_recruiting NCT01265979
WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib No drug interventions Not Available Not Available completed NCT01114087
Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility treatment Not Available completed NCT05905887
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor treatment 2 recruiting NCT04811833
Gastrointestinal Anastomosis Using MonoPlus® Suture No drug interventions Not Available Not Available withdrawn NCT03291054
Epacadostat and Pembrolizumab in Patients With GIST treatment 2 terminated NCT03353753
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies treatment 3 completed NCT00171977
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) treatment 4 completed NCT02866045
EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs No drug interventions diagnostic 3 unknown_status NCT02260505
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) prevention 3 completed NCT05408897
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD No drug interventions Not Available Not Available recruiting NCT06507683
Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST No drug interventions treatment Not Available recruiting NCT01031628
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients treatment 3 terminated NCT01289028
Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. treatment 3 completed NCT03092128
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment No drug interventions Not Available Not Available unknown_status NCT01646593
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy Not Available Not Available no_longer_available NCT02662478
Laparoscopic Resection of Large Gastric Stromal Tumors No drug interventions Not Available Not Available completed NCT00500188
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST treatment 2 completed NCT01091207
Sorafenib for Imatinib/Sunitinib-failed GIST treatment 2 completed NCT05697107
Ripretinib in Chinese Patients With Advanced GIST: a Real World Study Not Available Not Available active_not_recruiting NCT04258956
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy treatment 2 unknown_status NCT00290485
Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST) treatment 2 unknown_status NCT05493215
Imatinib TDM in GIST treatment 2 recruiting NCT02342600
SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor) treatment 2 withdrawn NCT00455559
Ph II Study of Perifosine Plus Gleevec for Patients With GIST treatment 2 completed NCT04825470
Liver Transplantation for Unresectable GIST Liver Metastases No drug interventions treatment Not Available not_yet_recruiting NCT05385549
5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk treatment 2 recruiting NCT05400018
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients No drug interventions Not Available Not Available completed NCT00782834
Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) treatment 2 terminated NCT04106024
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial treatment 2 unknown_status NCT01933958
Regorafenib Post-marketing Surveillance in Japan Not Available Not Available completed NCT01381822
Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors treatment 1 unknown_status NCT01275222
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors treatment 1 / 2 completed NCT02800330
The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib treatment 4 completed NCT01172548
Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) prevention 2 completed NCT02638766
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST treatment 2 completed NCT06523582
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients No drug interventions Not Available Not Available recruiting NCT01689376
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program) Not Available Not Available no_longer_available NCT00278876
Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation treatment 2 completed NCT01462994
Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST) No drug interventions diagnostic 3 completed NCT05500391
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring No drug interventions health_services_research 2 recruiting NCT04282980
A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST) treatment 2 completed NCT04000529
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies treatment 1 terminated NCT02931929
MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT No drug interventions diagnostic 1 / 2 completed NCT03602092
Observational Registry Data on GIST Patients No drug interventions Not Available Not Available recruiting NCT00812240
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) treatment 3 terminated NCT05867901
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence No drug interventions Not Available Not Available recruiting NCT03944304
Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib. treatment 2 recruiting NCT05245968
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) treatment 1 recruiting NCT01265810
Caphosol in Oral Mucositis Due to Targeted Therapy No drug interventions supportive_care 3 completed NCT00444795
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene Not Available Not Available completed NCT04409223
Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib treatment 3 terminated NCT05132738
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy treatment Not Available unknown_status NCT00457743
A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) treatment 1 / 2 completed NCT05461664
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA No drug interventions Not Available Not Available unknown_status NCT03165721
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer treatment 2 terminated NCT05080621
Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) treatment 1 / 2 withdrawn NCT01270984
Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects treatment 1 completed NCT05197933
Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach No drug interventions treatment Not Available recruiting NCT05751733
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST treatment Not Available recruiting NCT06431451
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients With Advanced GISTs No drug interventions Not Available Not Available not_yet_recruiting NCT01694277
Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib treatment 3 completed NCT01863745
Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment treatment 2 completed NCT00877045
Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting No drug interventions Not Available Not Available completed NCT00135005
Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST) treatment 1 completed NCT04714983
DNX-2440 for Resectable Colorectal Liver Metastasis No drug interventions treatment 1 suspended NCT00471328
Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib treatment 3 completed NCT00718211
A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore No drug interventions Not Available Not Available completed NCT01178307
Symptom Inventory for Gastrointestinal Stromal Tumors No drug interventions Not Available Not Available unknown_status NCT01541709
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI treatment 2 active_not_recruiting NCT05938309
A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors No drug interventions Not Available Not Available recruiting NCT00756509
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib treatment 4 active_not_recruiting NCT04343456
Salvage Surgery for Patients With Metastatic GIST With Rego No drug interventions Not Available Not Available completed NCT02401815
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors treatment 1 / 2 completed NCT04276415
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) No drug interventions treatment 1 terminated NCT02607332
Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib treatment 2 completed NCT01151852
Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT treatment 3 completed NCT01440959
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258 treatment 2 completed NCT05464875
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors No drug interventions Not Available Not Available unknown_status NCT04181970
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK No drug interventions Not Available Not Available recruiting NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT05800106
A Bioequivalence Study of Sunitinib Malate Capsules. treatment 1 completed NCT00137449
Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor treatment 2 completed NCT02571036
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies treatment 1 completed NCT00751036
Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg treatment 3 terminated NCT03601234
Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors No drug interventions treatment Not Available unknown_status NCT00293124
Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors treatment 3 completed NCT03609424
PDR001 Plus Imatinib for Metastatic or Unresectable GIST treatment 1 / 2 completed NCT05366816
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST treatment 2 recruiting NCT00570635
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib treatment 2 completed NCT02268435
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors treatment 1 withdrawn NCT06087263
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting. treatment 2 recruiting NCT02171286
The Oncopanel Pilot (TOP) Study No drug interventions Not Available Not Available completed NCT04254939
A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor treatment 1 / 2 completed NCT01524848
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib treatment 2 completed NCT06208748
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST treatment 2 recruiting NCT01396148
A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor treatment 2 completed NCT05440357
Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study No drug interventions Not Available Not Available recruiting NCT05565066
A Real-world Comparison of FNB and FNA in IHC-required Lesions. No drug interventions Not Available Not Available completed NCT00688766
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib treatment 3 terminated NCT00564265
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo No drug interventions Not Available Not Available completed NCT04825574
Study for Patients Previously Treated in Avapritinib Clinical Trials treatment 4 active_not_recruiting NCT02232620
A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors treatment 2 terminated NCT00716820
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). Not Available Not Available completed NCT00507273
Gastrointestinal Stromal Tumors (GIST) Registry No drug interventions Not Available Not Available completed NCT01478373
Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib treatment 2 completed NCT04908176
A Drug-drug Interaction Study of Avapritinib and Midazolam other 1 active_not_recruiting NCT00718562
Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib treatment 2 completed NCT01421680
The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients No drug interventions supportive_care Not Available completed NCT03673501
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib treatment 3 active_not_recruiting NCT05001204
68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor No drug interventions diagnostic 0 unknown_status NCT00237172
Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) treatment 2 completed NCT05665868
Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy No drug interventions supportive_care Not Available recruiting NCT03862768
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment treatment Not Available unknown_status NCT02488746
Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST) No drug interventions Not Available Not Available terminated NCT06326346
GIST Oral Paclitaxel(Liporaxel) treatment 2 not_yet_recruiting NCT00976612
Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK Not Available Not Available completed NCT01271712
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) treatment 3 completed NCT01483014
Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) treatment 2 completed NCT00441155
Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib treatment 1 completed NCT05661643
The Efficacy and Safety of Temozolomide in SDH-deficient GIST treatment 2 recruiting NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors treatment 2 active_not_recruiting NCT02884154
Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors No drug interventions diagnostic Not Available completed NCT00265798
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate treatment 2 active_not_recruiting NCT00041197
Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery treatment 3 completed NCT00005597
S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors treatment 2 completed NCT01389583
A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients treatment 2 unknown_status NCT00685828
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor treatment 3 unknown_status NCT00004911
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction No drug interventions supportive_care 1 / 2 completed NCT01643278
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic treatment 1 completed NCT02776878
A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST treatment Not Available unknown_status NCT00025415
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction treatment 1 completed NCT03493152
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019) Not Available Not Available temporarily_not_available NCT00009906
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor treatment 3 terminated NCT00005049
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer treatment 2 completed NCT00003939
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma treatment 2 completed NCT02763748
the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor No drug interventions treatment Not Available unknown_status NCT01769248
Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle No drug interventions diagnostic Not Available completed NCT04143048
A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules No drug interventions Not Available Not Available unknown_status NCT00006357
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma treatment 1 / 2 completed NCT00769782
Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor No drug interventions treatment 2 completed NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT01560260
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors treatment 2 completed NCT02426762
Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery No drug interventions prevention 2 unknown_status NCT02686944
A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors treatment 1 completed NCT02164240
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST treatment 1 completed NCT00573404
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors treatment 1 terminated NCT00103168
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor treatment 3 completed NCT01110668
Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) treatment 2 completed NCT01068769
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor treatment 2 completed NCT04933669
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors treatment 2 recruiting NCT00004910
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction No drug interventions supportive_care 1 / 2 completed NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT00764595
Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor treatment 2 completed NCT00004895
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery supportive_care 2 completed NCT01267695
Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor treatment 2 completed NCT02924714
SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST No drug interventions other Not Available suspended NCT00954655
Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001 No drug interventions Not Available Not Available completed NCT00028002
Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor treatment 2 completed NCT00397384
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer treatment 1 completed NCT00098579
Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery treatment 1 completed NCT00324987
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor treatment 3 terminated NCT01613053
Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination Not Available Not Available no_longer_available NCT00091078
Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery treatment 2 terminated NCT02185937
Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy No drug interventions other 1 terminated NCT00112632
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor treatment 2 completed NCT02353052
Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST No drug interventions Not Available Not Available unknown_status NCT01154452
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma treatment 1 / 2 completed NCT00041249
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma treatment 2 completed NCT00075218
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) treatment 3 completed NCT01039519
A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) treatment 2 completed NCT01751919
A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) treatment 1 completed NCT02336724
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor treatment 2 unknown_status NCT00112463
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma treatment 2 completed NCT02103322
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions treatment 2 / 3 completed NCT04256226
Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor No drug interventions Not Available Not Available completed NCT01865565
Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy No drug interventions Not Available Not Available completed NCT00087074
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor treatment 2 completed NCT00005874
Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas treatment 2 completed NCT00428220
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. treatment Not Available completed NCT02880020
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery treatment 2 completed NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT00005862
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas treatment 2 completed NCT01774162
EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration No drug interventions diagnostic Not Available completed NCT02576080
Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index diagnostic 3 unknown_status NCT00069940
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor treatment 1 completed NCT00372567
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors treatment 3 terminated NCT00030667
Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood treatment 2 completed NCT00777504
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors No drug interventions treatment 4 unknown_status NCT00956072
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate treatment 3 terminated NCT00025246
Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery treatment 2 completed NCT02931981
Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor No drug interventions Not Available Not Available unknown_status NCT00568750
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors treatment 2 completed NCT01404650
Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor treatment 2 completed NCT02734823
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor No drug interventions Not Available Not Available withdrawn NCT02606097
Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation treatment 2 completed NCT00633295
Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor treatment 2 completed NCT02508532
(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors treatment 1 completed NCT05160168
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) treatment 1 / 2 terminated NCT02877368
Sarcopenia in Patients With Gastrointestinal Stromal Tumours No drug interventions Not Available Not Available completed NCT05354388
Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study No drug interventions Not Available Not Available unknown_status NCT03440515
Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor treatment 2 completed NCT04633122
A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib treatment 2 completed NCT02365441
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) treatment 2 active_not_recruiting NCT06619275
Ripretinib (QINLOCK®) According to Current SmPC Not Available Not Available recruiting NCT04530981
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST treatment 1 completed NCT04148092
Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST Not Available Not Available approved_for_marketing NCT00998751
Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST) treatment 2 completed NCT06630234
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) No drug interventions treatment 1 / 2 not_yet_recruiting NCT04557969
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis No drug interventions Not Available Not Available recruiting NCT04821895
Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients No drug interventions Not Available Not Available recruiting NCT01391611
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST) treatment 2 terminated NCT00785785
A Study of Nilotinib Versus Imatinib in GIST Patients treatment 3 completed NCT05489237
A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST 1] treatment 1 recruiting NCT01034670
Advanced Gastrointestinal Endoscopic Imaging diagnostic Not Available terminated NCT00867113
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) treatment 2 completed NCT00767234
Permission to Collect Blood Over Time for Research No drug interventions Not Available Not Available terminated NCT02452424
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors treatment 1 / 2 terminated NCT01316263
A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors treatment 2 terminated NCT02574663
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors treatment 1 completed NCT03594422
A Study of HQP1351 in Patients With GIST or Other Solid Tumors treatment 1 recruiting NCT02443948
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) No drug interventions Not Available Not Available unknown_status NCT00464620
Trial of Dasatinib in Advanced Sarcomas treatment 2 completed NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen No drug interventions treatment 1 completed NCT03404076
Unifying Advanced Treatment With Advanced Imaging No drug interventions Not Available Not Available completed NCT00780494
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma treatment 2 completed NCT01048281
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma No drug interventions Not Available Not Available recruiting NCT03158103
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) treatment 1 completed NCT01294202
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST treatment 2 completed NCT01991379
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) treatment 1 / 2 active_not_recruiting NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT05453292
Endoscopic Ultrasound Radiofrequency Ablation for GISTs No drug interventions treatment Not Available recruiting NCT06640361
A Study of Olverembatinib in SDH-deficient GIST. No drug interventions treatment 3 not_yet_recruiting NCT05734105
A Study of Ripretinib Vs Sunitinib in Patients with Advanced GIST with Specific KIT Exon Mutations Who Were Previously Treated with Imatinib treatment 3 recruiting NCT03082079
Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) No drug interventions treatment Not Available unknown_status NCT05443087
TARGETed Therapy Drug MONITOring in DIGestive Oncology No drug interventions treatment Not Available recruiting NCT05641233
Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy No drug interventions prevention 1 / 2 recruiting NCT04097093
Long-term Surival of GIST Patients ≥ 10 Years on Imatinib No drug interventions Not Available Not Available withdrawn NCT00687778
11C-Acetate PET/CT Non-FDG-Avid Tumors No drug interventions Not Available Not Available unknown_status NCT03862885
Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST Not Available Not Available approved_for_marketing NCT01323400
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) treatment 2 completed NCT05895942
Exploring the Molecular Mechanism Based on KIT Mutation Not Available Not Available recruiting NCT00618319
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) treatment 2 completed NCT03880617
Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy No drug interventions Not Available Not Available completed NCT01459757
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib No drug interventions Not Available Not Available completed NCT01874665
A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor treatment 2 completed NCT03424876
To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib. Not Available Not Available unknown_status NCT04599660
Study in Low Risk Gastrointestinal Stromal Tumor (GISTs) No drug interventions Not Available Not Available completed NCT04927260
French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients Not Available Not Available active_not_recruiting NCT05957367
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies treatment 1 / 2 recruiting NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas treatment 1 recruiting NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors treatment 1 / 2 recruiting NCT01376505
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors treatment 1 completed NCT01770405
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract No drug interventions Not Available Not Available completed NCT00399152
Perifosine + Sunitinib Malate for Patients With Advanced Cancers treatment 1 completed NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT02246322
A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. No drug interventions diagnostic Not Available unknown_status NCT03465722
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST treatment 3 completed NCT01768325
Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core) No drug interventions diagnostic Not Available completed NCT02015065
Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors treatment 2 completed NCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study No drug interventions Not Available Not Available recruiting NCT05474794
Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions No drug interventions diagnostic Not Available recruiting NCT00979329
Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST No drug interventions Not Available Not Available completed NCT04761172
NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours No drug interventions treatment 2 / 3 unknown_status NCT03050268
Familial Investigations of Childhood Cancer Predisposition No drug interventions Not Available Not Available recruiting NCT00979381
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor No drug interventions Not Available Not Available completed NCT04138381
Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) treatment 1 / 2 active_not_recruiting NCT01089595
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST) treatment 2 terminated NCT01246843
Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib No drug interventions Not Available Not Available completed NCT02009423
Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence treatment 3 terminated NCT00367861
Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance treatment 3 completed NCT01506336
Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib treatment 2 completed NCT03963544
Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST) Not Available Not Available recruiting NCT03426722
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors treatment 3 completed NCT01768104
ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors No drug interventions treatment Not Available unknown_status NCT02889328
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs treatment 2 completed NCT02712112
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs treatment 2 completed NCT01031056
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers No drug interventions Not Available Not Available withdrawn NCT04193553
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure treatment 2 completed NCT04566614
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies No drug interventions Not Available Not Available recruiting NCT02331914
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure No drug interventions Not Available Not Available recruiting NCT00700258
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] Not Available Not Available completed NCT01402089
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients treatment 4 completed